Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ: AGIO · Real-Time Price · USD
54.62
+0.21 (0.39%)
Nov 20, 2024, 4:00 PM EST - Market closed
Agios Pharmaceuticals Market Cap
Agios Pharmaceuticals has a market cap or net worth of $3.11 billion as of November 21, 2024. Its market cap has increased by 139.82% in one year.
Market Cap
3.11B
Enterprise Value
1.52B
1-Year Change
139.82%
Ranking
Category
Stock Price
$54.62
Market Cap Chart
Since July 24, 2013, Agios Pharmaceuticals's market cap has increased from $919.00M to $3.11B, an increase of 238.95%. That is a compound annual growth rate of 11.37%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Nov 20, 2024 | 3.12B | 150.26% |
Dec 29, 2023 | 1.24B | -19.33% |
Dec 30, 2022 | 1.54B | -13.57% |
Dec 31, 2021 | 1.79B | -40.52% |
Dec 31, 2020 | 3.00B | 6.73% |
Dec 31, 2019 | 2.81B | 4.81% |
Dec 31, 2018 | 2.68B | -3.76% |
Dec 29, 2017 | 2.79B | 58.97% |
Dec 30, 2016 | 1.75B | -28.25% |
Dec 31, 2015 | 2.44B | -37.12% |
Dec 31, 2014 | 3.89B | 420.55% |
Dec 31, 2013 | 746.50M | -18.77% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
BrightSpring Health Services | 3.25B |
Bausch Health Companies | 3.08B |
MoonLake Immunotherapeutics | 3.06B |
Merus | 3.03B |
PTC Therapeutics | 3.03B |
Inari Medical | 3.00B |
Dyne Therapeutics | 2.99B |
Amedisys | 2.93B |